Osteopontin (OPN), a secreted adhesive glycoprotein, is significantly
overexpressed in a variety of experimental models of malignancy. Moreo
ver, increased levels of OPN have been detected in the blood of patien
ts with metastatic carcinoma. To investigate OPN expression and distri
bution in human carcinomas directly, we studied a wide variety of comm
on tumors by Northern analysis, in situ hybridization, and immunohisto
chemistry. All 14 tumors studied by Northern analysis showed very subs
tantial increases in OPN messenger (m)RNA when compared to correspondi
ng normal tissues. Moreover, intense labeling for OPN mRNA was detecte
d in 71 of 76 carcinomas studied by in situ hybridization. In most of
the carcinomas studied (colon, stomach, duodenum, pancreas, breast, lu
ng, bladder, prostate, ovary, thyroid, and melanoma), tumor cells did
not label detectably for OPN mRNA; however, macrophages intimately ass
ociated with tumor cells labeled strongly for the OPN transcript. In c
arcinomas of the kidney and endometrium, both tumor cells and host mac
rophages labeled strongly for OPN mRNA. The presence of OPN mRNA in ma
crophages was particularly pronounced at the edge of tumors (ie, tumor
/stroma interface) and in areas of tumor necrosis. Although in most ca
ses tumor cells did not label detectably for OPN mRNA, both tumor cell
s and macrophages stained for OPN protein, suggesting that OPN mRNA, b
oth tumor cells and macrophages stained for OPN protein, suggesting th
at OPN secreted by macrophages may bind to tumor cells, possibly throu
gh the glycine-arginine-glycine-aspartate-serine cell binding domain i
n OPN. Collectively, these data suggest that OPN functions in adhesive
interactions at the tumor/host interface and thereby may influence pr
ocesses such as invasion and metastasis.